How have VXZB shares performed in 2024?

iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock was trading at $14.48 on January 1st, 2024. Since then, VXZB shares have decreased by 0.5% and is now trading at $14.4099. View the best growth stocks for 2024 here .

What does VXZB invest in?

iPath Series B S&P 500 VIX Mid-Term Futures ETN is a multi asset fund issued by Barclays Capital. VXZB focuses on volatility investments and follows the S&P 500 VIX Mid-Term Futures Index Total Return.

How do I buy shares of iPath Series B S&P 500 VIX Mid-Term Futures ETN?

Shares of VXZB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

BATS:VXZB

iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZB) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free VXZB Stock Alerts

$14.41

+0.09 (+0.63%)

(As of 04/19/2024 ET)

Compare

Today's Range: $14.20
▼
$14.52
50-Day Range: $13.49
▼
$14.71
52-Week Range: N/A

Volume: 53,037 shs
Average Volume: N/A
Market Capitalization: N/A

Assets Under Management: N/A
Dividend Yield: N/A
Net Expense Ratio: 0.89%

Stock Analysis Chart

Get iPath Series B S&P 500 VIX Mid-Term Futures ETN alerts:

VXZB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VXZB ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive VXZB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath Series B S&P 500 VIX Mid-Term Futures ETN and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Barclays Capital
Fund Name: iPath Series B S&P 500 VIX Mid-Term Futures ETN
Tax Classification: Exchange-Traded Note
Stock Exchange: BATS
Current Symbol: BATS:VXZB
Inception Date: 1/17/2018
Fund Manager: N/A
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Multi Asset
Benchmark: S&P 500 VIX Mid-Term Futures Index Total Return
Category: Absolute Returns
Focus: Volatility
Development Level: Developed Markets
Region: North America
Number of Holdings: 0

Fund Statistics

Assets Under Management: $0.00
Average Daily Volume: $20,335.60
Discount/Premium: 0.00%

Administrator, Advisor and Custodian

Administrator: N/A
Advisor: N/A
Custodian: N/A
Distributor: N/A
Transfer Agent: N/A
Trustee: N/A
Lead Market Maker: Virtu Financial

Miscellaneous

Outstanding Shares: N/A
Beta: N/A

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

iPath Series B S&P 500 VIX Mid-Term Futures ETN Expenses

Type	VXZB	Volatility ETFs	Multi Asset ETFs	BATS ETFs	All ETFs
Management Fee	0.00%	0.76%	0.69%	0.56%	0.51%
Other Expenses	0.00%	0.43%	0.79%	0.51%	0.58%
Total Expense	0.00%	0.88%	1.21%	0.68%	0.70%
Fee Waiver	0.00%	-0.23%	-0.69%	-0.34%	-0.57%
Net Expense	0.89%	0.89%	0.94%	0.63%	0.58%